Two studies have shown that inhibition of miR-21 protects mice from developing PAH, associated with preservation of TGFβ signalling in VSMCs through restored expression of key proteins such as BMPR2 [142,163]. The gene discussed is TGFB1; the disease is pulmonary arterial hypertension.